Thomas James Lynch MD
Richard Sackler and Jonathan Sackler Professor of Medicine (Medical Oncology); Director, Cancer Center
Lung cancer; EGFR; Targeted therapy; Personalized medicine
As director of the MGH Thoracic Oncology Center, Lynch made important contributions to developmental therapeutics and defining the optimal treatment for patients with lung cancer. He has pioneered the use of molecular testing for mutations in the epidermal growth factor receptor gene to select patients who can benefit from targeted lung cancer therapies.